Apap

Description

The product is available in two National Drug Code (NDC) configurations: 17714-013-01, which contains 100 units per count, and 17714-013-10, which contains 1000 units per count.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, backache, minor pain of arthritis, the common cold, toothache, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are instructed to take 2 tablets every 6 hours as needed while symptoms persist. It is imperative that they do not exceed 6 tablets within a 24-hour period unless specifically directed by a healthcare professional. Additionally, the duration of use should not exceed 10 days unless advised by a doctor.

For children under 12 years of age, consultation with a healthcare provider is recommended prior to administration.

Contraindications

Use is contraindicated in patients who exceed the recommended dosage, as this may lead to liver damage. No other contraindications have been identified.

Warnings and Precautions

This product contains acetaminophen, which poses a significant risk of liver damage if not used according to the specified guidelines. The maximum recommended daily dosage is 6 tablets (3,000 mg) within a 24-hour period. Severe liver injury may occur if the following conditions are met: exceeding 4,000 mg of acetaminophen in a 24-hour period, concomitant use with other medications containing acetaminophen, or consumption of three or more alcoholic beverages daily while using this product.

Healthcare professionals should advise patients against using this product in conjunction with any other medications that contain acetaminophen, whether prescription or over-the-counter. If there is uncertainty regarding the acetaminophen content of a medication, patients should be directed to consult a healthcare provider or pharmacist.

Patients with a known allergy to acetaminophen or any of the inactive ingredients in this formulation should avoid its use. Additionally, individuals with liver disease should seek medical advice prior to using this product. Caution is also warranted for patients taking warfarin, a blood-thinning medication; they should consult a healthcare professional before use.

Patients are instructed to discontinue use and contact a healthcare provider if any of the following occur: pain worsens or persists beyond 10 days, fever intensifies or lasts more than 3 days, redness or swelling develops, or new symptoms arise, as these may indicate a serious underlying condition.

In the event of an overdose, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay. Prompt medical intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly related to liver health. The product contains acetaminophen, and exceeding the maximum daily dose of 6 tablets (3,000 mg) within 24 hours may lead to severe liver damage. This risk is heightened if patients consume more than 4,000 mg of acetaminophen in a 24-hour period, use other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

Patients are advised not to use this product in conjunction with any other drug containing acetaminophen, whether prescription or non-prescription. Individuals with known allergies to acetaminophen or any inactive ingredients in this formulation should also refrain from use.

Before using this product, patients with liver disease should consult a healthcare professional. Additionally, those taking the blood-thinning medication warfarin should seek advice from a doctor or pharmacist prior to use.

Patients are instructed to discontinue use and consult a healthcare provider if pain worsens or persists for more than 10 days, if fever worsens or lasts more than 3 days, if redness or swelling occurs, or if new symptoms arise, as these may indicate a serious condition.

For pregnant or breastfeeding individuals, it is recommended to seek guidance from a health professional before using this product.

Drug Interactions

Patients taking warfarin, a blood-thinning medication, should consult with a healthcare professional prior to using this drug. The interaction between this medication and warfarin may necessitate careful monitoring of coagulation parameters to ensure therapeutic efficacy and minimize the risk of adverse effects. Adjustments to the dosage of either medication may be required based on clinical judgment and patient response.

Packaging & NDC

Below are the non-prescription pack sizes of Apap (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 2 tablets every 6 hours as needed for symptom relief, with a maximum of 6 tablets in a 24-hour period, unless otherwise directed by a physician. Treatment should not exceed 10 days without medical advice.

In the event of an overdose, prompt medical attention is essential for both adults and pediatric patients, even if no immediate signs or symptoms are apparent.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment should be advised that this product contains acetaminophen, which may pose a risk of liver damage. The maximum recommended daily dose is 6 tablets (3,000 mg) within a 24-hour period. It is critical to note that severe liver damage may occur if the total daily intake of acetaminophen exceeds 4,000 mg, whether from this product or in combination with other medications containing acetaminophen. Additionally, consumption of 3 or more alcoholic drinks per day while using this product may further increase the risk of liver injury.

Patients with liver disease are strongly encouraged to consult a healthcare professional prior to using this product to assess the appropriateness of treatment and to discuss potential risks associated with acetaminophen use. Monitoring of liver function may be warranted in patients with compromised liver function to ensure safety and efficacy.

Overdosage

In the event of overdosage, it is critical to recognize the potential risks associated with excessive intake of this product. The maximum recommended daily dose is 6 tablets, equating to 3,000 mg within a 24-hour period. Exceeding this dosage can lead to serious health complications.

Risk of Severe Liver Damage Severe liver damage may occur if an individual ingests more than 4,000 mg of acetaminophen within a 24-hour timeframe. Additionally, the risk of liver damage is heightened when this product is taken concurrently with other medications that contain acetaminophen. Healthcare professionals should be vigilant in assessing the total acetaminophen intake from all sources to prevent potential toxicity.

Furthermore, the consumption of three or more alcoholic beverages daily while using this product significantly increases the risk of severe liver damage. It is advisable for healthcare providers to counsel patients on the dangers of combining alcohol with acetaminophen-containing products.

Recommended Actions In cases of suspected overdosage, immediate medical attention is warranted. Healthcare professionals should initiate appropriate management procedures, which may include monitoring liver function and considering the administration of N-acetylcysteine as an antidote, depending on the severity of the overdose and the time elapsed since ingestion. Prompt intervention is essential to mitigate the risk of irreversible liver injury.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion.

Patients should be informed about the risks associated with overdose. It is crucial to communicate that taking more than the recommended dose may lead to liver damage. In the event of an overdose, patients must seek medical help or contact a Poison Control Center immediately. Emphasize the importance of quick medical attention for both adults and children, even if no signs or symptoms are initially apparent.

Storage and Handling

The product is supplied in bulk packaging, which requires dispensing into a child-resistant closure. It must be stored in a tight, light-resistant container as defined by the United States Pharmacopeia (USP).

Storage conditions should be maintained within a temperature range of 15-30 °C (59-86 °F) to ensure product stability and efficacy.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. Additionally, it is important to keep the medication out of reach of children to ensure safety. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Apap, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)